Scemblix 40 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F3P3C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,956
Award facts
- Contract value 100% obligated
- $15,956.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,956.33 to AmerisourceBergen Drug Corp for SCEMBLIX 40 MG tablets (60 count) with a firm fixed price contract type. This non-set-aside award was issued on January 6, 2026, with an ultimate completion date of January 28, 2026. The contract will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is well-positioned to fulfill this order as a subsidiary of Cencora, Inc. The company maintains an extensive portfolio of pharmaceutical product deliveries to federal agencies, particularly the DLA and its medical supply chain, demonstrating consistent capability to meet government procurement requirements through open competition. The delivery of SCEMBLIX, a specialty pharmaceutical product, aligns with the broader mission of the parent IDC to supply essential medications and medical commodities across multiple therapeutic domains to support military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F3P3C?
SPE2DR26F3P3C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F3P3C worth?
The government has obligated $15,956 on SPE2DR26F3P3C.
Is contract SPE2DR26F3P3C an order under another contract?
Yes. SPE2DR26F3P3C is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3P3C competed?
The extent of competition for SPE2DR26F3P3C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award